Drug intelligence / Profile preview

Jianpi Huoxue Decoction (Shuguang Hospital)

Development stage: Unknown
Lead developer: Shuguang Hospital
Administration: Oral

Overview

Jianpi Huoxue Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine for the treatment of non-alcoholic fatty liver disease (NAFLD). Based on TCM principles, the formula is designed to address the "spleen deficiency and blood stasis" syndrome, a common pattern identified in NAFLD patients. The decoction aims to strengthen the spleen's transportive function and promote blood circulation to resolve hepatic steatosis and inflammation. It is currently being evaluated in clinical trials to establish its efficacy in improving liver enzymes and reducing intrahepatic fat content.

Other names: Jianpi Huoxue FormulaJianpi Huoxue Tang

Beyond the preview

Go deeper on Jianpi Huoxue Decoction (Shuguang Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianpi Huoxue Decoction (Shuguang Hospital).

Explore the full profile